These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1532707)

  • 1. [A case of recurrent esophageal cancer maintaining complete long-term response after 5'-DFUR and ftorafur administrations].
    Mizuno Y; Makino N; Matsumoto K; Fujimura N; Yamamoto E; Ishida C; Koyama S; Naitoh M; Maezato K; Matsukawa Y
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):533-6. PubMed ID: 1532707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term complete response in a case of unresectable rectal cancer following chemoradiation].
    Musha N; Sunami E; Sasaki M; Saito H; Sando N; Setu Y; Setu M; Oka K
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):131-3. PubMed ID: 10660746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
    Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
    Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of local recurrence of rectal cancer in long-term responding to combined therapy of low-dose CPT-11 and 5'-DFUR].
    Gotoh J; Akabane H; Kita K; Fujiyoshi M; Hirokata G; Imai K; Kawai T; Yanagida N; Nakano S; Takahashi M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1349-51. PubMed ID: 16969040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with esophageal cancer recurrence responding to S-1 combined with cisplatin (CDDP)].
    Kanamori N; Fujii M; Takahashi T; Wakabayashi K; Kochi M; Sou K; Takayama T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1459-61. PubMed ID: 17876146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent breast cancer responding to long-term treatment with 5'-DFUR combined with MPA].
    Kimura M; Koida T; Sekihara M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1183-5. PubMed ID: 8751807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy].
    Shitara K; Munakata M; Ishiguro A; Hoshi Y; Okada R; Tomioka R; Mitobe S; Sakata Y; Ebina A; Aoki M
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1137-41. PubMed ID: 16912535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
    Fan QX; Wang R; Lu P; Zhao YF; Lu TY; Han JW; Wang JS; Luo SX; Lu SP; Wang GJ; Geng L; Zhang MZ; Ma ZY; Song M; Wu XA; Chen XB; Jiao ZM; Wang RL
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):937-9. PubMed ID: 19173998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of gastrointestinal cancers with major responses to sequential methotrexate 5-FU plus 5'-DFUR].
    Tamura Y; Sakata Y; Ogasawara H; Itoh T; Furukohri N; Saitoh S; Tsushima K; Baba T; Munakata A; Yoshida Y
    Gan To Kagaku Ryoho; 1989 May; 16(5):2109-12. PubMed ID: 2525005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent chemoradiation using daily low-dose CDDP and UFT-E for postoperative recurrent esophageal cancers].
    Akagi Y; Hashimoto Y; Takiyama W; Mukaida H; Murakami Y; Ito K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1993-7. PubMed ID: 15570927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line combination chemotherapy with docetaxel for cisplatin-pretreated refractory metastatic esophageal cancer: a preliminary report of initial experience.
    Tanaka T; Fujita H; Sueyoshi S; Tanaka Y; Sasahara H; Mori N; Nagano T; Yamana H; Shirouzu K
    Chemotherapy; 2007; 53(6):449-53. PubMed ID: 17952006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
    Murakami S; Yamamoto Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1147-9. PubMed ID: 17637560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
    Suzuki M; Aida I; Ohwada M; Sato I; Tamura T; Kasuga Y
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):253-8. PubMed ID: 7857101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
    Oguro A; Nanri M; Miyamoto Y; Ikoma H; Chimori Y; Yamane E; Nishioka B
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1767-9. PubMed ID: 9757204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fluoropyrimidines may not reduce the risk of postoperative recurrence in colorectal cancer associated with mesenteric lymph node metastasis.
    Ogata Y; Torigoe S; Matono K; Sasatomi T; Ishibashi N; Shida S; Ohkita A; Fukumitu T; Mizobe T; Ikeda S; Ogo S; Ozasa H; Shirouzu K
    Int Surg; 2007; 92(6):314-9. PubMed ID: 18402123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer.
    Yoshino S; Furuya T; Shimizu R; Ozasa H; Nishimura T; Fukuda S; Kawaoka T; Hazama S; Oka M
    Anticancer Res; 2013 Jun; 33(6):2629-33. PubMed ID: 23749919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with 5-FU modulated by low-dose CDDP for advanced cancers and recurrent cases of metastasis].
    Shinkai K; Kida H; Hisano H; Shibasaki S; Yano H; Nomura M
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):329-32. PubMed ID: 10065096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.